Filgrastim biosimilar (Tanvex BioPharma)

非格司亭生物类似药（Tanvex BioPharma）

Report date: 2024/07/04 09:56:30

Base Information

Drug NameFilgrastim biosimilar (Tanvex BioPharma)
Drug Alias Name重组人粒细胞刺激因子（Tanvex BioPharma）rhG-CSF (Tanvex BioPharma)非格司亭生物仿制药（Tanvex BioPharma）Recombinant human granulocyte macrophage colony stimulating factor (Tanvex BioPharma)Filgrastim-TXID +[7] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsChemotherapy-Induced Febrile NeutropeniaFebrile NeutropeniaNeutropenia +[4] 
Global Approved IndicationsChemotherapy-Induced Febrile NeutropeniaFebrile NeutropeniaNeutropenia +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryCanada
Original Approved Date2021/10/17
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTanvex BioPharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesTanvex BioPharma IncTanvex Biopharma Usa Inc
Inactive CompaniesN/A
Active IndicationsChemotherapy-Induced Febrile NeutropeniaFebrile NeutropeniaNeutropenia +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeL03AA02
Related LinksWikipediaDrugBank